Cart
sales@molnova.com
BAY-179
CAS No. 2764880-87-5
BAY-179( —— )
Catalog No. M37661 CAS No. 2764880-87-5
BAY-179 is a potent, selective, and species cross-reactive complex I inhibitor used for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 53 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 77 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 271 | In Stock |
|
| 100MG | 377 | In Stock |
|
| 200MG | 500 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-179
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY-179 is a potent, selective, and species cross-reactive complex I inhibitor used for cancer research.
-
DescriptionBAY-179 is a potent, selective, and species cross-reactive complex I inhibitor (IC50=79 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorMitochondrial Metabolism
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2764880-87-5
-
Formula Weight415.51
-
Molecular FormulaC23H21N5OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (150.42 mM; Ultrasonic (<60°C)
-
SMILESC(N1CCC(C2=NC(C3=CC=4C(O3)=CC=CC4)=CS2)CC1)C=5NC=6C(N5)=NC=CC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mowat J, et al. Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179. ACS Med Chem Lett. 2022;13(3):348-357. Published 2022 Feb 18. ?
molnova catalog
related products
-
Methyl-β-D-galactopy...
Methyl beta-D-glucopyranoside also known as alpha-methyl-D -mannoside or beta -D-glucopyranoside methyl. Within the cell methyl beta-D-glucopyranoside is primarily located in the cytoplasm.
-
Zamaporvint
Zamaporvint (RXC004) is a selective, orally active and potent inhibitor of the Wnt pathway that acts on the membrane-bound fatty acyltransferase porcupine to block Wnt ligand palmitoylation, secretion, and pathway activation.
-
Nemorubicin
Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?
